MANAMA: An astonishing 5,000 people have stepped forward to volunteer to take part in the phase III Covid-19 vaccine clinical trials in Bahrain.

Bahrainis and expats, inspired by members of the Royal Family, have flocked to show their support to the campaign launched under the theme ‘Volunteering for Humanity’.

Around 2,000 volunteers have signed up in the past few days, added to the 3,000 already taking part, and now only 1,000 people are needed to reach the local target figure.

The trials were launched in Bahrain in co-operation with the UAE through G24 Healthcare using a potential vaccine developed by Sinopharm CNBG, the world’s sixth largest producer of vaccines.

Over the weekend a video was released by the Health Ministry highlighting the ongoing initiative and showed how people from all walks of life were volunteering.

DUTY

The video featured senior government officials, MPs, community policemen and health care workers, who urged the public to take part in the trial as a national duty.

Only days earlier, His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince, Deputy Supreme Commander and First Deputy Premier, volunteered too, as reported in the GDN.

People aged 18 and above who have not been infected with the coronavirus can take part in the trial of the ‘inactivated vaccine’ which is expected to create immunity by producing antibodies.

Volunteers are asked to go to the clinical facility at the Bahrain International Exhibition and Convention Centre.

Some will be given the potential vaccine and others a placebo as part of the study as the search for a safe and life-saving solution gathers pace around the globe.

Health officials urge people not to miss out from playing their part … ‘volunteer for humanity today’ … your country needs you and so does the world.

© Copyright 2020 www.gdnonline.com

Copyright 2020 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.